The administrative core is an essential component of our Program Project Grant. Dr. David Harrison, Principal Investigator, will meet either in person or by conference call with each project leader at least monthly on an individual basis. We also plan quarterly group meetings of all investigators via conference calls to review progress and to plan further research strategies, particularly emphasizing areas in which advances in one project may lead to the formulation of new hypotheses, or otherwise alter the conduct of studies in a different programmatic area. We also plan yearly meetings of the PPG investigators and at least two members of the external and internal advisory committees. Biostatistical support is a critical component of any research program. Dr. Yu Shyr, Professor and Chief, Division of Cancer Biostatistics, Department of Biostatistics, has served all components of this proposal as a consultant and collaborator and will continue this role throughout the duration of the program. Support for Dr. Shyr is therefore budgeted in this core. Investigators in this Program will be supported by the administrative services of this Core, particularly in preparation of non-competing renewals, in financial management, and in organization of the annual mini-site visits of the Advisory Committees. The administrative core will be responsible for coordinating the office management of the PPG. Ms. Berman, the Vanderbilt Grants Manager in Clinical Pharmacology and Ms. Amy Shelton, the Clinical Pharmacology business manager, will oversee all administrative aspects of the grant including progress report submission.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL129941-03
Application #
9528630
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Program Officer
Maric-Bilkan, Christine
Project Start
Project End
Budget Start
2018-08-01
Budget End
2019-07-31
Support Year
3
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
079917897
City
Nashville
State
TN
Country
United States
Zip Code
37232
Ye, Zhongde; Li, Guangjin; Kim, Chulwoo et al. (2018) Regulation of miR-181a expression in T cell aging. Nat Commun 9:3060
Dikalov, Sergey I; Polienko, Yuliya F; Kirilyuk, Igor (2018) Electron Paramagnetic Resonance Measurements of Reactive Oxygen Species by Cyclic Hydroxylamine Spin Probes. Antioxid Redox Signal 28:1433-1443
Zhang, Hui; Watanabe, Ryu; Berry, Gerald J et al. (2018) Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis. Circulation 137:1934-1948
Tan, Wei-Qiang; Fang, Qing-Qing; Shen, Xiao Z et al. (2018) Angiotensin-converting enzyme inhibitor works as a scar formation inhibitor by down-regulating Smad and TGF-?-activated kinase 1 (TAK1) pathways in mice. Br J Pharmacol 175:4239-4252
Dikalov, Sergey I; Dikalova, Anna E; Morozov, Denis A et al. (2018) Cellular accumulation and antioxidant activity of acetoxymethoxycarbonyl pyrrolidine nitroxides. Free Radic Res 52:339-350
Norlander, Allison E; Madhur, Meena S; Harrison, David G (2018) The immunology of hypertension. J Exp Med 215:21-33
Uribe, Jorge A; Aggarwal, Ishita; Witthayaweerasak, Juthamat et al. (2018) Refractory Giant Cell Arteritis Complicated by Vision Loss From Optic Atrophy and Maculopathy Associated With Pachymeningitis. J Neuroophthalmol 38:17-23
Li, Yinyin; Goronzy, Jörg J; Weyand, Cornelia M (2018) DNA damage, metabolism and aging in pro-inflammatory T cells: Rheumatoid arthritis as a model system. Exp Gerontol 105:118-127
Goronzy, Jörg J; Hu, Bin; Kim, Chulwoo et al. (2018) Epigenetics of T cell aging. J Leukoc Biol 104:691-699
Weyand, Cornelia M; Berry, Gerald J; Goronzy, Jörg J (2018) The immunoinhibitory PD-1/PD-L1 pathway in inflammatory blood vessel disease. J Leukoc Biol 103:565-575

Showing the most recent 10 out of 50 publications